, Tracking Stock Market Picks
Enter Symbol:
Arrowhead Research Corporation (ARWR) [hlAlert]

down 79.08 %

Arrowhead Research Corporation (ARWR) rated Buy with price target $45 by Deutsche Bank

Posted on: Wednesday,  Mar 5, 2014  1:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy Arrowhead Research Corporation (NASDAQ: ARWR) on 03/05/2014, when the stock price was $27.11. Since
then, Arrowhead Research Corporation has lost 79.09% as of 01/25/2016's recent price of $5.67.
If you would have followed this Deutsche Bank's recommendation on ARWR, you would have lost 79.08% of your investment in 691 days.

Arrowhead Research Corporation (Arrowhead) is a development stage nanotechnology company. The Company is focused to bring products to market through its subsidiaries and investments in the healthcare, electronics, and clean energy industries. As of September 30, 2008, Arrowhead operated two majority owned Subsidiaries, two wholly owned Subsidiaries and had minority investments in two early stage nanotechnology companies focused on developing and commercializing nanotech products and applications, including anti-cancer drugs, ribonucleic acid interference (RNAi) therapeutics, regenerative therapeutics, advanced drug delivery technology, energy storage technology, and carbon-based electronics. In April 2008, the Company announced the completion of merger between two of its subsidiaries, Insert Therapeutics, Inc. and Calando Pharmaceuticals, Inc. In May 2008, the Company announced the sale of its majority owned subsidiary, Aonex Technologies, Inc. to AmberWave Systems.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/5/2014 1:25 PM Buy
27.11 45.00
as of 10/17/2014
1 Week up  1.25 %
1 Month down  -59.86 %
3 Months down  -41.94 %
1 YTD down  -76.20 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy